SynPhNe develops medical wearable devices aimed at aiding rehabilitation for stroke and brain‑injury patients. Its core products are wearable devices designed to support patient recovery after neurological injury. The company was reported to have completed a financing round in March 2024. The reported financing totaled $5 million in a Series A. Event Horizon is named as the investor in the report.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2024